the developer of a first-in-class polymer treatment for chronic lower back pain
Gelmetix has raised €5.8M across 1 funding round from 1 investor, most recently a Series C round in May 2021. Based in Manchester, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-05-14 | Series C |
| €5.8M |
| Seneca Partners |
| View deal → |
